National comprehensive cancer network recommendations for drugs without US food and drug administration approval in metastatic breast cancer: A cross-sectional study.

Etan, Tal; Amir, Eitan; Tibau, Ariadna; Yerushalmi, Rinat; Moore, Assaf; Shepshelovich, Daniel; Goldvaser, Hadar

Etan, Tal; Amir, Eitan; Tibau, Ariadna; Yerushalmi, Rinat; Moore, Assaf; Shepshelovich, Daniel; Goldvaser, Hadar.

Afiliação

Etan T; Institute of Oncology, Tel Aviv Sourasky Medical Center, Weizmann St 6, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Chaim Levanon St 30, Tel Aviv, Israel.
Amir E; Princess Margaret Cancer Centre, University of Toronto, 610 University Ave, Toronto, Canada. Electronic address: Eitan.Amir@uhn.ca.
Tibau A; Department of Oncology, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau and Universitat Autònoma de Barcelona, Carrer de Sant Quintí 89, Barcelona, Spain. Electronic address: atibau@santpau.cat.
Yerushalmi R; Sackler Faculty of Medicine, Tel Aviv University, Chaim Levanon St 30, Tel Aviv, Israel; Institute of Oncology, Rabin Medical Center, Zeev Jabutinsky Rd 39, Petah- Tikva, Israel. Electronic address: rinaty@clalit.org.il.
Moore A; Sackler Faculty of Medicine, Tel Aviv University, Chaim Levanon St 30, Tel Aviv, Israel; Institute of Oncology, Rabin Medical Center, Zeev Jabutinsky Rd 39, Petah- Tikva, Israel.
Shepshelovich D; Sackler Faculty of Medicine, Tel Aviv University, Chaim Levanon St 30, Tel Aviv, Israel; Internal medicine "T", Tel Aviv Sourasky Medical Center, Weizmann St 6, Tel Aviv, Israel.
Goldvaser H; Sackler Faculty of Medicine, Tel Aviv University, Chaim Levanon St 30, Tel Aviv, Israel; Institute of Oncology, Rabin Medical Center, Zeev Jabutinsky Rd 39, Petah- Tikva, Israel. Electronic address: hadar7g@gmail.com.

Cancer Treat Rev ; 91: 102113, 2020 Dec.

Article em En | MEDLINE | ID: mdl-33128993

Assuntos

Antineoplásicos/uso terapêutico; Neoplasias da Mama/tratamento farmacológico; Uso Off-Label; Neoplasias da Mama/metabolismo; Neoplasias da Mama/secundário; Estudos Transversais; Aprovação de Drogas; Feminino; Humanos; Receptor ErbB-2; Estados Unidos; United States Food and Drug Administration

Palavras-chave

Anti-cancer drugs; FDA; Metastatic breast cancer; NCCN; Off-label

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Uso Off-Label / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: America do norte Idioma: En Revista: Cancer Treat Rev Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google